Loading…

C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice

Plasma C-reactive protein (CRP) concentration is a strong predictor of atherosclerosis. However, to date, there is no in vivo evidence that CRP is proatherogenic. We studied the effect of human CRP transgene (tg) expression, under basal and turpentine-stimulated conditions, on atherosclerosis in apo...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2004-02, Vol.109 (5), p.647-655
Main Authors: PAUL, Antoni, KO, Kerry W. S, LI, Lan, YECHOOR, Vijay, MCCRORY, Mark A, SZALAI, Alexander J, CHAN, Lawrence
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c531t-6dc3d2e397ba2a59dbc17425b86654bdc5c6dbe10680ddfc64ceb093e2a34b83
cites cdi_FETCH-LOGICAL-c531t-6dc3d2e397ba2a59dbc17425b86654bdc5c6dbe10680ddfc64ceb093e2a34b83
container_end_page 655
container_issue 5
container_start_page 647
container_title Circulation (New York, N.Y.)
container_volume 109
creator PAUL, Antoni
KO, Kerry W. S
LI, Lan
YECHOOR, Vijay
MCCRORY, Mark A
SZALAI, Alexander J
CHAN, Lawrence
description Plasma C-reactive protein (CRP) concentration is a strong predictor of atherosclerosis. However, to date, there is no in vivo evidence that CRP is proatherogenic. We studied the effect of human CRP transgene (tg) expression, under basal and turpentine-stimulated conditions, on atherosclerosis in apolipoprotein (apo) E-/- mice. Aortic atherosclerotic lesions in 29-week-old male mice were 48% larger (P
doi_str_mv 10.1161/01.CIR.0000114526.50618.24
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80146283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>546113981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c531t-6dc3d2e397ba2a59dbc17425b86654bdc5c6dbe10680ddfc64ceb093e2a34b83</originalsourceid><addsrcrecordid>eNpdkdtKxDAQhoMouh5eQYqgd62ZHFvvZPEEgiDehzSZaqTbrklX8O3N6sqCuZiQ4fsnM_MTcga0AlBwSaGaPzxXNB8AIZmqJFVQV0zskBlIJkohebNLZhloSs0ZOyCHKb3np-Ja7pMDEFqIRssZ8fMyonVT-MRiGccJw1BY57DHaCdMxfT2k3-NmFIYh2LsCptzcUyuX8eQirViOfZhOf4VuCk9dsEFHKZiERwek73O9glPNvcRebm9eZnfl49Pdw_z68fSSQ5TqbzjniFvdGuZlY1vHWjBZFsrJUXrnXTKtwhU1dT7zinhsKUNR2a5aGt-RC5-y-Y-PlaYJrMIKY_S2wHHVTI1BaFYzTN49g98H1dxyK0ZBkxzraXI0NUv5PKYKWJnljEsbPwyQM3aB0PBZB_M1gfz44Nha_Hp5odVu0C_lW4Wn4HzDWCTs30X7eBC2nJSKNCM82-U0pKH</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>212737754</pqid></control><display><type>article</type><title>C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice</title><source>EZB Electronic Journals Library</source><creator>PAUL, Antoni ; KO, Kerry W. S ; LI, Lan ; YECHOOR, Vijay ; MCCRORY, Mark A ; SZALAI, Alexander J ; CHAN, Lawrence</creator><creatorcontrib>PAUL, Antoni ; KO, Kerry W. S ; LI, Lan ; YECHOOR, Vijay ; MCCRORY, Mark A ; SZALAI, Alexander J ; CHAN, Lawrence</creatorcontrib><description>Plasma C-reactive protein (CRP) concentration is a strong predictor of atherosclerosis. However, to date, there is no in vivo evidence that CRP is proatherogenic. We studied the effect of human CRP transgene (tg) expression, under basal and turpentine-stimulated conditions, on atherosclerosis in apolipoprotein (apo) E-/- mice. Aortic atherosclerotic lesions in 29-week-old male mice were 48% larger (P&lt;0.02) in turpentine-treated mice and 34% larger (P&lt;0.05) in untreated CRPtg+/0/apoE-/- mice. Turpentine treatment per se did not affect the extent of atherosclerosis in CRP transgenic or nontransgenic apoE-/- mice. Transgenic mice exhibited lower plasma complement C3 but increased deposition of CRP and C3 in the lesions, which suggests that CRP stimulated activation of complement within the lesion. There was more intense and widespread vascular cell adhesion molecule-1 and collagen staining in the lesions of CRPtg+/0/apoE-/- mice than in CRPtg0/0/apoE-/- littermates. Lesions of CRPtg+/0/apoE-/- mice contained increased angiotensin type 1 receptor (AT1-R) transcripts and displayed increased AT1-R immunostaining compared with those of CRPtg0/0/apoE-/- mice. There was no difference in blood pressure in the 2 types of mice, which indicates that the proatherogenic effect of CRP-associated AT1-R overexpression is local and not mediated by its hypertensive properties. Human CRP transgene expression causes accelerated aortic atherosclerosis in apoE-/- mice. CRP was detected in the lesion, which was associated with increased C3 deposition and increased AT1-R, vascular cell adhesion molecule-1, and collagen expression. These data document a proatherogenic role for CRP in vivo.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/01.CIR.0000114526.50618.24</identifier><identifier>PMID: 14744975</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Animals ; Aorta - chemistry ; Aorta - pathology ; Apolipoproteins E - genetics ; Arteriosclerosis - metabolism ; Arteriosclerosis - pathology ; Biological and medical sciences ; Blood and lymphatic vessels ; C-Reactive Protein - analysis ; C-Reactive Protein - genetics ; C-Reactive Protein - physiology ; Cardiology. Vascular system ; Complement C3 - analysis ; Disease Progression ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Female ; Humans ; Kinetics ; Male ; Medical sciences ; Mice ; Mice, Knockout ; Mice, Transgenic ; Nitric Oxide Synthase - metabolism ; Nitric Oxide Synthase Type II ; Nitric Oxide Synthase Type III ; Phenotype ; Receptor, Angiotensin, Type 1 - metabolism ; Risk Factors</subject><ispartof>Circulation (New York, N.Y.), 2004-02, Vol.109 (5), p.647-655</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Feb 10 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c531t-6dc3d2e397ba2a59dbc17425b86654bdc5c6dbe10680ddfc64ceb093e2a34b83</citedby><cites>FETCH-LOGICAL-c531t-6dc3d2e397ba2a59dbc17425b86654bdc5c6dbe10680ddfc64ceb093e2a34b83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15461723$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14744975$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>PAUL, Antoni</creatorcontrib><creatorcontrib>KO, Kerry W. S</creatorcontrib><creatorcontrib>LI, Lan</creatorcontrib><creatorcontrib>YECHOOR, Vijay</creatorcontrib><creatorcontrib>MCCRORY, Mark A</creatorcontrib><creatorcontrib>SZALAI, Alexander J</creatorcontrib><creatorcontrib>CHAN, Lawrence</creatorcontrib><title>C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Plasma C-reactive protein (CRP) concentration is a strong predictor of atherosclerosis. However, to date, there is no in vivo evidence that CRP is proatherogenic. We studied the effect of human CRP transgene (tg) expression, under basal and turpentine-stimulated conditions, on atherosclerosis in apolipoprotein (apo) E-/- mice. Aortic atherosclerotic lesions in 29-week-old male mice were 48% larger (P&lt;0.02) in turpentine-treated mice and 34% larger (P&lt;0.05) in untreated CRPtg+/0/apoE-/- mice. Turpentine treatment per se did not affect the extent of atherosclerosis in CRP transgenic or nontransgenic apoE-/- mice. Transgenic mice exhibited lower plasma complement C3 but increased deposition of CRP and C3 in the lesions, which suggests that CRP stimulated activation of complement within the lesion. There was more intense and widespread vascular cell adhesion molecule-1 and collagen staining in the lesions of CRPtg+/0/apoE-/- mice than in CRPtg0/0/apoE-/- littermates. Lesions of CRPtg+/0/apoE-/- mice contained increased angiotensin type 1 receptor (AT1-R) transcripts and displayed increased AT1-R immunostaining compared with those of CRPtg0/0/apoE-/- mice. There was no difference in blood pressure in the 2 types of mice, which indicates that the proatherogenic effect of CRP-associated AT1-R overexpression is local and not mediated by its hypertensive properties. Human CRP transgene expression causes accelerated aortic atherosclerosis in apoE-/- mice. CRP was detected in the lesion, which was associated with increased C3 deposition and increased AT1-R, vascular cell adhesion molecule-1, and collagen expression. These data document a proatherogenic role for CRP in vivo.</description><subject>Animals</subject><subject>Aorta - chemistry</subject><subject>Aorta - pathology</subject><subject>Apolipoproteins E - genetics</subject><subject>Arteriosclerosis - metabolism</subject><subject>Arteriosclerosis - pathology</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>C-Reactive Protein - analysis</subject><subject>C-Reactive Protein - genetics</subject><subject>C-Reactive Protein - physiology</subject><subject>Cardiology. Vascular system</subject><subject>Complement C3 - analysis</subject><subject>Disease Progression</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Female</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Knockout</subject><subject>Mice, Transgenic</subject><subject>Nitric Oxide Synthase - metabolism</subject><subject>Nitric Oxide Synthase Type II</subject><subject>Nitric Oxide Synthase Type III</subject><subject>Phenotype</subject><subject>Receptor, Angiotensin, Type 1 - metabolism</subject><subject>Risk Factors</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpdkdtKxDAQhoMouh5eQYqgd62ZHFvvZPEEgiDehzSZaqTbrklX8O3N6sqCuZiQ4fsnM_MTcga0AlBwSaGaPzxXNB8AIZmqJFVQV0zskBlIJkohebNLZhloSs0ZOyCHKb3np-Ja7pMDEFqIRssZ8fMyonVT-MRiGccJw1BY57DHaCdMxfT2k3-NmFIYh2LsCptzcUyuX8eQirViOfZhOf4VuCk9dsEFHKZiERwek73O9glPNvcRebm9eZnfl49Pdw_z68fSSQ5TqbzjniFvdGuZlY1vHWjBZFsrJUXrnXTKtwhU1dT7zinhsKUNR2a5aGt-RC5-y-Y-PlaYJrMIKY_S2wHHVTI1BaFYzTN49g98H1dxyK0ZBkxzraXI0NUv5PKYKWJnljEsbPwyQM3aB0PBZB_M1gfz44Nha_Hp5odVu0C_lW4Wn4HzDWCTs30X7eBC2nJSKNCM82-U0pKH</recordid><startdate>20040210</startdate><enddate>20040210</enddate><creator>PAUL, Antoni</creator><creator>KO, Kerry W. S</creator><creator>LI, Lan</creator><creator>YECHOOR, Vijay</creator><creator>MCCRORY, Mark A</creator><creator>SZALAI, Alexander J</creator><creator>CHAN, Lawrence</creator><general>Lippincott Williams &amp; Wilkins</general><general>American Heart Association, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20040210</creationdate><title>C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice</title><author>PAUL, Antoni ; KO, Kerry W. S ; LI, Lan ; YECHOOR, Vijay ; MCCRORY, Mark A ; SZALAI, Alexander J ; CHAN, Lawrence</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c531t-6dc3d2e397ba2a59dbc17425b86654bdc5c6dbe10680ddfc64ceb093e2a34b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animals</topic><topic>Aorta - chemistry</topic><topic>Aorta - pathology</topic><topic>Apolipoproteins E - genetics</topic><topic>Arteriosclerosis - metabolism</topic><topic>Arteriosclerosis - pathology</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>C-Reactive Protein - analysis</topic><topic>C-Reactive Protein - genetics</topic><topic>C-Reactive Protein - physiology</topic><topic>Cardiology. Vascular system</topic><topic>Complement C3 - analysis</topic><topic>Disease Progression</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Female</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Knockout</topic><topic>Mice, Transgenic</topic><topic>Nitric Oxide Synthase - metabolism</topic><topic>Nitric Oxide Synthase Type II</topic><topic>Nitric Oxide Synthase Type III</topic><topic>Phenotype</topic><topic>Receptor, Angiotensin, Type 1 - metabolism</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>PAUL, Antoni</creatorcontrib><creatorcontrib>KO, Kerry W. S</creatorcontrib><creatorcontrib>LI, Lan</creatorcontrib><creatorcontrib>YECHOOR, Vijay</creatorcontrib><creatorcontrib>MCCRORY, Mark A</creatorcontrib><creatorcontrib>SZALAI, Alexander J</creatorcontrib><creatorcontrib>CHAN, Lawrence</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>PAUL, Antoni</au><au>KO, Kerry W. S</au><au>LI, Lan</au><au>YECHOOR, Vijay</au><au>MCCRORY, Mark A</au><au>SZALAI, Alexander J</au><au>CHAN, Lawrence</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2004-02-10</date><risdate>2004</risdate><volume>109</volume><issue>5</issue><spage>647</spage><epage>655</epage><pages>647-655</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Plasma C-reactive protein (CRP) concentration is a strong predictor of atherosclerosis. However, to date, there is no in vivo evidence that CRP is proatherogenic. We studied the effect of human CRP transgene (tg) expression, under basal and turpentine-stimulated conditions, on atherosclerosis in apolipoprotein (apo) E-/- mice. Aortic atherosclerotic lesions in 29-week-old male mice were 48% larger (P&lt;0.02) in turpentine-treated mice and 34% larger (P&lt;0.05) in untreated CRPtg+/0/apoE-/- mice. Turpentine treatment per se did not affect the extent of atherosclerosis in CRP transgenic or nontransgenic apoE-/- mice. Transgenic mice exhibited lower plasma complement C3 but increased deposition of CRP and C3 in the lesions, which suggests that CRP stimulated activation of complement within the lesion. There was more intense and widespread vascular cell adhesion molecule-1 and collagen staining in the lesions of CRPtg+/0/apoE-/- mice than in CRPtg0/0/apoE-/- littermates. Lesions of CRPtg+/0/apoE-/- mice contained increased angiotensin type 1 receptor (AT1-R) transcripts and displayed increased AT1-R immunostaining compared with those of CRPtg0/0/apoE-/- mice. There was no difference in blood pressure in the 2 types of mice, which indicates that the proatherogenic effect of CRP-associated AT1-R overexpression is local and not mediated by its hypertensive properties. Human CRP transgene expression causes accelerated aortic atherosclerosis in apoE-/- mice. CRP was detected in the lesion, which was associated with increased C3 deposition and increased AT1-R, vascular cell adhesion molecule-1, and collagen expression. These data document a proatherogenic role for CRP in vivo.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>14744975</pmid><doi>10.1161/01.CIR.0000114526.50618.24</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2004-02, Vol.109 (5), p.647-655
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_80146283
source EZB Electronic Journals Library
subjects Animals
Aorta - chemistry
Aorta - pathology
Apolipoproteins E - genetics
Arteriosclerosis - metabolism
Arteriosclerosis - pathology
Biological and medical sciences
Blood and lymphatic vessels
C-Reactive Protein - analysis
C-Reactive Protein - genetics
C-Reactive Protein - physiology
Cardiology. Vascular system
Complement C3 - analysis
Disease Progression
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
Humans
Kinetics
Male
Medical sciences
Mice
Mice, Knockout
Mice, Transgenic
Nitric Oxide Synthase - metabolism
Nitric Oxide Synthase Type II
Nitric Oxide Synthase Type III
Phenotype
Receptor, Angiotensin, Type 1 - metabolism
Risk Factors
title C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T21%3A06%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=C-reactive%20protein%20accelerates%20the%20progression%20of%20atherosclerosis%20in%20apolipoprotein%20E-deficient%20mice&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=PAUL,%20Antoni&rft.date=2004-02-10&rft.volume=109&rft.issue=5&rft.spage=647&rft.epage=655&rft.pages=647-655&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/01.CIR.0000114526.50618.24&rft_dat=%3Cproquest_cross%3E546113981%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c531t-6dc3d2e397ba2a59dbc17425b86654bdc5c6dbe10680ddfc64ceb093e2a34b83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=212737754&rft_id=info:pmid/14744975&rfr_iscdi=true